The role of AI-powered molecular profiling in the diagnosis and management of cancers of unknown primary: a case report and literature review.

This case highlights the potential role of artificial intelligence-powered molecular profiling in resolving diagnostic uncertainty in cancers of unknown primary, where traditional methods like imaging and tumor markers are inconclusive.

By identifying actionable biomarkers, molecular profiling facilitates personalized therapy, improving clinical outcomes.

Further research is needed to validate the broader clinical utility of artificial intelligence-driven molecular profiling as a decision-support tool for precision oncology.